MetLife, Inc.
MET Financial Services Insurance - Life NYSE
$71.83
$-1.11 (-1.52%)
Open: $71.30 | High: $71.90 | Low: $69.55 | Prev Close: $72.94
Market Cap: $47.33B
Volume: 3.1M | Avg: 3.9M
Last updated: March 09, 2026 at 02:03 AMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 490
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 15.25 |
| P/B Ratio | 1.68 |
| P/S Ratio | 0.62 |
| EPS | $4.71 |
| Beta | 0.75 |
| Shares Outstanding | 658.89M |
| 52-Week High | $85.00 |
| 52-Week Low | $65.21 |
| SMA 50 | $77.39 |
| SMA 200 | $78.50 |
| Dividend Yield | 3.16% |
| Annual Dividend | $2.27 |
| Next Earnings | April 29, 2026 08:00 PM ET |
Financial Ratios
| Gross Margin | 25.6% |
| Operating Margin | 6.1% |
| Net Margin | 4.4% |
| ROE | 12.0% |
| ROA | 0.5% |
| Debt/Equity | 0.68 |
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
Balance Sheet
| Total Assets | $745.17B |
| Total Liabilities | $716.25B |
| Total Equity | $28.40B |
|
|
|
| Cash | $22.03B |
| Total Debt | $19.33B |
| Net Debt | $-2,703,000,000 |
Income Statement
| Revenue | $77.08B |
| Gross Profit | $28.02B |
| Operating Income | $4.66B |
| Net Income | $3.38B |
|
|
|
| EBITDA | $5.72B |
| Revenue/Share | $114.49 |
Cash Flow
| Operating CF | $17.09B |
| CapEx | N/A |
| Free Cash Flow | $17.09B |
|
|
|
| Book Value/Share | $43.49 |
| Tangible Book/Share | $29.04 |
| Equity/Share | $42.71 |
Technical Indicators
| RSI (14) | 34.76 Neutral |
| MACD |
-1.67
Signal: -1.14
|
| Volatility | 31.81% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | -11.18% |
| Sharpe Ratio | -0.76 Poor |
| Volatility (Ann.) | 23.29% Moderate |
| MET (1Y) | -11.18% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | -24.21% |
Sector Comparison (Financial Services)
| Metric | MET | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 15.25 | 47.88 | 28% |
| P/B Ratio | 1.68 | 4.21 | 34% |
| ROE (%) | 12.01% | 19.83% | 37% |
| Net Margin (%) | 4.44% | 18.96% | 3% |
| Stock Score | 490 | 429.0 | 64% |
| 1Y Return (%) | -11.18 % | +8.10 % | 8% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MET | $71.83 | $71.81 | $72.88 | $74.55 | $77.33 | $78.49 | 34.76 | -1.67 | 31.81% | 690765 | Strong Short | Bearish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the MET stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| MET | MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited | Neutral | businesswire.com | Read More |
| MET | MetLife, Inc. $MET Shares Sold by Barclays PLC | Neutral | defenseworld.net | Read More |
| MET | MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend | Neutral | businesswire.com | Read More |
| MET | MetLife, Inc. (MET) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript | Neutral | seekingalpha.com | Read More |
| MET | The Sleeper Financial Stock That Could Surge Before Wall Street Notices | Neutral | fool.com | Read More |
Recent Insider Trading
No recent insider trading data available for MET
Company Information
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
| CEO | Michel Abbas Khalaf |
| Employees | 45000 |
| Country | US |
| IPO Date | 2000-04-05 |
| Exchange | NYSE |
| Website | https://www.metlife.com |
| Sector | Financial Services |
| Industry | Insurance - Life |
Similar Stocks (Financial Services - Insurance - Life)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category